Lombard Medical Technologies PLC

Industry:

Medical Devices & Equipment

Description

Lombard Medical Technologies (LMT) develops, manufactures and markets stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The Company was established in July 2000 and currently employs over 100 people at Didcot, Sheffield and Ayrshire in the UK and in the USA. The Company also has trade investments in an emerging medical device company.

Lombard Medical Technologies PLC is listed on the London Stock Exchange (AIM) under the symbol LMT.

Products & Services

medical products, specialist cardiovascular device, stent grafts

News Archive

On the move Pharmaceutical Executive Europe (Online); 8/25/2009 ...Dr Jackson joins from Response Genetics where he was executive vice president. Dave Clennell joins from Lombard Medical Technologies and has extensive experience in FDArelated markets. Adriann Sax has been appointed as chief business officer... ...more

German Bayer MaterialScience acquires UK PolyBioMed. ADP News Germany; 11/17/2009 ...chemical and pharmaceutical group Bayer AG (ETR:BAY), shook hands with UK-based medical device company Lombard Medical Technologies PLC (LON: LMT) to take over the latter's subsidiary PolyBioMed, Bayer announced Tuesday. Both parties... ...more